Overview

Bioequivalence Study of Pravastatin Sodium Tablets 80 mg Under Fasting Conditions

Status:
Completed
Trial end date:
2002-12-01
Target enrollment:
Participant gender:
Summary
This is a single Dose Two-Way Crossover Fasting Bioequivalence Study of Pravastatin 80 mg Tablets of Dr.Reddy's Laboratories Limited with Pravachol 80 mg, Bristol Myers Squibb in Healthy Volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Dr. Reddy's Laboratories Limited
Treatments:
Pravastatin